No difference in leprosy treatment outcomes comparing 12- and 24-dose multidrug regimens: a preliminary study Nenhuma diferença na evolução da hanseníase entre os esquemas terapêuticos de 12 versus 24 doses: um estudo preliminar

• Main Authors: Anna Maria Sales (Author), Paulo Chagastelles Sabroza (Author), José Augusto da Costa Nery (Author), Nádia Cristina Dupprè (Author), Euzenir Nunes Sarno (Author)
• Format: Knjiga
• Izdano: Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz, 2007-04-01T00:00:00Z.
• Teme: article
• Online dostop: Connect to this object online.

A comparative study was performed on the initial and final bacillary indexes of 213 multibacillary leprosy patients who received 12 doses (Group 1: 128 patients) or 24 doses (Group 2: 85 patients) of multidrug therapy (MDT/WHO) to measure the effectiveness of the two regimens. All patients were eval...